Loading...
Loading...
EXAI| Name | Value |
|---|---|
| Revenues | 3.0M |
| Cost of Revenue | 6.3M |
| Gross Profit | -3.3M |
| Operating Expense | 42.8M |
| Operating I/L | -46.5M |
| Other Income/Expense | 3.8M |
| Interest Income | 4.2M |
| Pretax | -42.7M |
| Income Tax Expense | -6.8M |
| Net Income/Loss | -36.0M |
Exscientia plc is an AI-driven pharmatech company specializing in discovering, designing, and developing small molecule drug candidates. The company offers an end-to-end AI solution for target identification, drug candidate design, translational models, and patient selection. Its platform enables the design of candidate drug molecules and provides AI-guided assessment for patient drug therapies.
